PhysioGenix’s Substantial Growth in 2010 Expected to Continue in 2011

PhysioGenix experienced a tremendous year through the completion of a new research facility, addition of capabilities and record high sales. Milwaukee, WI (PRWEB) March 23, 2011 -- PhysioGenix, already a leader in customer focused contract research, expanded their research facilities, capabilities and research models in 2010. “We experienced tremendous growth in 2010 and anticipate additional growth in 2011,” stated PhysioGenix’s Director of Sales Darin Evans. PhysioGenix was a...

U.S. Scientists Contribute to Japan Earthquake and Pacific Tsunami Relief Effort

PhysioGenix, a diabetes and cardiovascular Preclinical Contract Research Organization, donates money to the American Red Cross to aid in the Japan earthquake and Pacific tsunami relief effort. Milwaukee, WI (PRWEB) March 20, 2011 -- PhysioGenix has donated to the American Red Cross to help provide relief for the recent earthquake and tsunami victims. PhysioGenix has been in e-mail contact with several of their Japanese colleagues who have informed them that they and their families are all...

Neuroscientist steers research into neurological disorders

Scientists at the Queensland Brain Institute have uncovered a vital clue into how the brain is wired, which could eventually steer research into nervous system disorders such as Parkinson's disease and cognitive disorders including...

Small molecule with high impact

Researchers from the vaccinology and applied microbiology department at the Helmholtz Center for Infection Research in Braunschweig, Germany, have now found a new molecule with the capacity of improving responses to vaccines. The synthetic compound, the so-called c-di-IMP, might be more than just a potent vaccine enhancer. The scientists expect to create new vaccination strategies based on c-di-IMP. The group's results have now been published in the current issue of the scientific journal...

Enanta Nominates EDP-239 as Lead Development Candidate for NS5A HCV Inhibitor Program

WATERTOWN, Mass., March 2 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day...

CombinatoRx scores $40M payout on FDA approval

CombinatoRx's complex merger deal with Neuromed will pay off with a $40 million milestone earned with today's announcement that the FDA has approved Exalgo, a once-daily pain therapy. Covidien, which partnered on the program, will handle the commercial rollout and fork over the...

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in...

Molecular imaging technique uses ultrasound and microscopic bubbles to target cancer cells

An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular...

Dietary factors influence ovarian cancer survival rates

Dietary factors influence ovarian cancer survival rates March 1, 2010 2009 estimates projected that in the United States alone 21,550 new cases of ovarian cancer would be diagnosed and 14,600 women would die of the disease. Often diagnosed in late stages, ovarian cancer has an asymptomatic onset and a relatively low 5-year survival rate of about 45%. Consequently investigation linked to survivorship is critical. A study published in the March 2010 issue of the Journal of the American...

Midwestern States Receive Least Federal Funding for Disease Prevention

Flat Federal Funding and Cuts in States Put America's Health At-Risk WASHINGTON, March 1 /PRNewswire-USNewswire/ -- Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF) today released a new report, Shortchanging America's Health: A State-By-State Look at How Public Health Dollars Are Spent, which finds federal spending for public health has been flat for nearly five years, while states around the country cut nearly $392 million for public health programs in the...